Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4

Clinical trial NCT01006031 · COMPLETED

Trial details

NCT number: NCT01006031
Sponsor: Sociedad Andaluza de Enfermedades Infecciosas
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Liver Cirrhosis Hepatitis C Virus HIV Infection

Start date: 2009-10-01
Primary completion: 2011-12-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.